Pharmaceutical Technology-09-02-2005

Pharmaceutical Technology

Applications of Poly(ethylene in Drug Delivery Systems: Part II

September 02, 2005

Articles

29

9

Poly(ethylene oxide) is gaining the attention of research and development organizations and its application is extending into a wide range of drug delivery systems.

Analytical Method Equivalency: An Acceptable Analytical Practice

September 02, 2005

Articles

29

9

Participants in a 2003 PhRMA workshop present the industry’s current thinking on developing analytical method equivalency, including the importance of sample selection, acceptance criteria, data evaluation, and documentation.

The Nation Needs a Comprehensive Pharmaceutical Engineering Education and Research System

September 02, 2005

Articles

29

9

The pharmaceutical science education system must be transformed.

September 2005

September 02, 2005

Articles

29

9

The US National Institute of Allergy and Infectious Diseases (NIAID, Bethesda, MD, www3.niaid.nih.gov) announced it will order two million doses of an avian influenza vaccine from Sanofi-Pasteur (Swiftwater, PA and Lyon, France, www. sanofipasteur.com). In April, the NIAID began a Phase I trial to evaluate the vaccine’s safety and ability to generate immunity against the H5N1 strain of avian flu, an illness that leads to severe disease and possible death in birds and humans.

Pilots and Partnerships Move RFID Forward

September 02, 2005

Articles

29

9

Cephalon partners with hardware and software providers to test item-level tagging.

Reshaping CMC Development Services

September 02, 2005

Articles

29

9

A summertime burst of acquisition activity in CMC development services prompts the question: a coincidence of timing or the start of a trend?

Wash. Rinse. Repeat

September 02, 2005

Articles

29

9

Technology's new monthly "Agent-in-Place" column distills true-life cautionary tales from the secret files of Control, a senior compliance officer.

Artificial Distinctions: Protein A Mimetic Ligands for Bioprocess Separations

September 02, 2005

Articles

29

9

Rapidly increasing cell-culture yields have thrown an increasing burden on downstream processes just as price pressures are pushing process developers to look for economies in every purification protocol. The time-honored, effective, and expensive war-horse, Protein A, is beginning to feel some competition from small-molecule mimetics.

In the Spotlight-September 2005

September 02, 2005

Articles

29

9

Pharmaceutical science and technology innovation

FDA Faces Multiple Challenges

September 02, 2005

Articles

29

9

Commissioner Crawford’s top priority is to restore public confidence in FDA oversight of drug safety and quality.